Virginia Meca‐Lallana

Neuromyelitis optica spectrum disorders

María Sepúlveda, Thaís Armangué, Núria Solà‐Valls et al. · Neurology Neuroimmunology & Neuroinflammation · 2016 · 152 citations · Full text

Medicine, Neurology, Immunopathology +14

Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS

José Ignacio Fernández-Velasco, Jens Kühle, Enric Monreal et al. · Neurology Neuroimmunology & Neuroinflammation · 2021 · 65 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies

Virginia Meca‐Lallana, Clara Aguirre, Beatrizdel Río et al. · Multiple Sclerosis and Related Disorders · 2020 · 59 citations · Full text

Life Sciences, Immunology, Neurology +17

Assessing fatigue in multiple sclerosis: Psychometric properties of the five-item Modified Fatigue Impact Scale (MFIS-5)

Virginia Meca‐Lallana, María Brañas-Pampillón, Yolanda Higueras et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2019 · 44 citations · Full text

Social Sciences, Neurology, Functional Assessment +16

Tumefactive multiple sclerosis lesions associated with fingolimod treatment: Report of 5 cases

Pedro Sánchez, Virginia Meca‐Lallana, José Vivancos · Multiple Sclerosis and Related Disorders · 2018 · 42 citations

Medicine, Neurology, Neuroscience +12